Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-24-000108

Options or other derivatives

  • Director acquired 65,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Hoerter Steven L. Director 2024-11-19 Grant or award · Stock Option (Right to Buy) +65,000 65,000 D
Loading xslF345X05/wk-form4_1732223821.xml…